The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The role of data mining in pharmacovigilance
Abstract
A principle concern of pharmacovigilance is the timely detection of adverse drug reactions that are novel by virtue of their clinical nature, severity and/or frequency. The cornerstone of this process is the scientific acumen of the pharmacovigilance domain expert. There is understandably an interest in developing database screening tools to assist human reviewers in identifying associations worthy of further investigation (i.e., signals) embedded within a database consisting largely of background 'noise' containing reports of no substantial public health significance. Data mining algorithms are, therefore, being developed, tested and/or used by health authorities, pharmaceutical companies and academic researchers. After a focused review of postapproval drug safety signal detection, the authors explain how the currently used algorithms work and address key questions related to their validation, comparative performance, deployment in naturalistic pharmacovigilance settings, limitations and potential for misuse. Suggestions for further research and development are offered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Causal Inference Using Potential Outcomes: Design, Modeling, Decisions
Rubin, D. B. (2005) · Journal of the American Statistical Association · doi:10.1198/016214504000001880 · Cited by 2,173
Evans, S. J. W., Waller, P. C., & Davis, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.677 · Cited by 1,802
On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9
Splawa-Neyman, J., Dabrowska, D. M., & Speed, T. P. (1990) · Statistical Science · doi:10.1214/ss/1177012031 · Cited by 1,627
A Bayesian neural network method for adverse drug reaction signal generation
Bate, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., & De Freitas, R. M. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050466 · Cited by 1,476
van Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R., & Egberts, A. C. G. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.668 · Cited by 1,372
Self-citationNature's Capacities and Their Measurement
Cartwright, N. (1994) · doi:10.1093/0198235070.001.0001 · Cited by 1,072
Dumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
Smoking and Lung Cancer: Recent Evidence and a Discussion of Some Questions
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.1.173 · Cited by 841
Szarfman, A., Machado, S. G., & O??Neill, R. T. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00001 · Cited by 700
Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17865-9 · Cited by 382
Attitudinal survey of voluntary reporting of adverse drug reactions
Eland, Belton, Grootheest, V., Meiners, Rawlins, & Stricker (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00060.x · Cited by 256
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
De Bruin, M. L., Pettersson, M., Meyboom, R. H. B., Hoes, A. W., & Leufkens, H. G. M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi092 · Cited by 245
Principles of Signal Detection in Pharmacovigilance
Meyboom, R. H. B., Egberts, A. C. G., Edwards, I. R., Hekster, Y. A., de Koning, F. H. P., & Gribnau, F. W. J. (1997) · Drug Safety · doi:10.2165/00002018-199716060-00002 · Cited by 239
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study
Coulter, D. M., Bate, A., Meyboom, R. H. B., Lindquist, M., & Edwards, I. R. (2001) · BMJ · doi:10.1136/bmj.322.7296.1207 · Cited by 234
Lindquist, M., St??hl, M., Bate, A., Edwards, I. R., & Meyboom, R. H. B. (2000) · Drug Safety · doi:10.2165/00002018-200023060-00004 · Cited by 230
Using MedDRA: Implications for Risk Management
Brown, E. G. (2004) · Drug Safety · doi:10.2165/00002018-200427080-00010 · Cited by 204
Belton, K. J. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050314 · Cited by 195
Belton, K., Lewis, S., Payne, S., Rawlins, M., & Wood, S. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04440.x · Cited by 187
Use of Measures of Disproportionality in Pharmacovigilance
Egberts, T. C. G., Meyboom, R. H. B., & van Puijenbroek, E. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00010 · Cited by 156
Practical pharmacovigilance analysis strategies
Gould, A. L. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.771 · Cited by 154
Data Mining for Fun and Profit
Adams, N. M., Blunt, G., Hand, D. J., & Kelly, M. G. (2000) · Statistical Science · doi:10.1214/ss/1009212753 · Cited by 151
Pharmacovigilance in the 21st Century: New Systematic Tools for an Old Problem
Szarfman, A., Tonning, J. M., & Doraiswamy, P. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1099.38090 · Cited by 140
van Puijenbroek, E., Egberts, T. C. G., Heerdink, E. R., et al. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000215 · Cited by 131
Attitudes to adverse drug reaction reporting in the Northern Region.
Bateman, D. N., Sanders, G., & Rawlins, M. D. (1992) · PubMed · Cited by 124
Almenoff, J. S., DuMouchel, W., Kindman, L. A., Yang, X., & Fram, D. M. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.885 · Cited by 124
van Puijenbroek, E., Egberts, T. C. G., Meyboom, R. H. B., & Leufkens, H. G. M. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00957.x · Cited by 122
Brown, E. G. (2003) · Drug Safety · doi:10.2165/00002018-200326030-00002 · Cited by 110
Data mining issues and opportunities for building nursing knowledge
Goodwin, L., VanDyne, M., Lin, S. M., & Talbert, S. (2003) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2003.09.020 · Cited by 106
ATTITUDES TO ADVERSE DRUG REACTION REPORTING BY MEDICAL PRACTITIONERS IN A NORTHERN ITALIAN DISTRICT
Cosentino, M., Leoni, O., Banfi, F., Lecchini, S., & Frigo, G. (1997) · Pharmacological Research · doi:10.1006/phrs.1996.0138 · Cited by 104
Comparison of data mining methodologies using Japanese spontaneous reports
Kubota, K., Koide, D., & Hirai, T. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.964 · Cited by 103
Li, X., Rao, S., Wang, Y., & Gong, B. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh563 · Cited by 103
False‐positives in spontaneous reporting: should we worry about them?
Bégaud, B., Moride, Y., Tubert‐Bitter, P., Chaslerie, A., & Haramburu, F. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04373.x · Cited by 89
Expecting the Unexpected — Drug Safety, Pharmacovigilance, and the Prepared Mind
Trontell, A. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048187 · Cited by 86
Underreporting of Adverse Drug Reactions: Attitudes of Irish doctors
Williams, D. J., & Feely, J. (1999) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02944353 · Cited by 80
Comparing data mining methods on the VAERS database
Banks, D., Woo, E. J., Burwen, D. R., Perucci, P., Braun, M. M., & Ball, R. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1107 · Cited by 79
Effects of Coding Dictionary on Signal Generation
Brown, E. G. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00009 · Cited by 77
Data Mining in Pharmacovigilance
Hauben, M., Patadia, V. K., Gerrits, C. M., Walsh, L., & Reich, L. (2005) · Drug Safety · doi:10.2165/00002018-200528100-00001 · Cited by 64
Self-citationStåhl, M., Lindquist, M., Edwards, I. R., et al. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.894 · Cited by 60
Safety Related Drug-Labelling Changes
Hauben, M., & Reich, L. (2004) · Drug Safety · doi:10.2165/00002018-200427100-00004 · Cited by 59
Self-citationBruin, M. L. D., van Puijenbroek, E., Egberts, T. C. G., Hoes, A. W., & Leufkens, H. G. M. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01569.x · Cited by 56
Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors
Spigset, O., Hägg, S., & Bate, A. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000066455.73432.d2 · Cited by 46
Hauben, M., Reich, L., & Chung, S. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0834-0 · Cited by 43
Self-citationHauben, M., & Reich, L. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004273936 · Cited by 41
Self-citationSome US Food and Drug Administration perspectives on data mining for pediatric safety Assessment
O’Neill, R. T., & Szarfman, A. (2001) · Current Therapeutic Research · doi:10.1016/s0011-393x(01)80071-0 · Cited by 40
Statistical Techniques for Signal Generation
Purcell, P. M., & Barty, S. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00005 · Cited by 36
Hauben, M., & Reich, L. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0951-4 · Cited by 36
Self-citationAre case-based reasoning and dissimilarity-based classification two sides of the same coin?
Perner, P. (2002) · Engineering Applications of Artificial Intelligence · doi:10.1016/s0952-1976(02)00020-9 · Cited by 29
Harvey, J. T., Turville, C., & Barty, S. (2004) · International Transactions in Operational Research · doi:10.1111/j.1475-3995.2004.00467.x · Cited by 13
Cited by
Large-Scale Bayesian Logistic Regression for Text Categorization
Genkin, A., Lewis, D. D., & Madigan, D. (2007) · Technometrics · doi:10.1198/004017007000000245 · Cited by 808
Self-citationStang, P. E., Ryan, P. B., Racoosin, J. A., Overhage, J. M., Hartzema, A. G., Reich, C., Welebob, E., Scarnecchia, T., & Woodcock, J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00010 · Cited by 441
“Other methods Bayesian logistic regression (32, 33) Columbia University This is a high-dimensional statistical method that is scalable to a substantial number of covariates, accommodating all drugs and conditions in a single model to predict occurrence of ADEs.”
MethodNovel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis
Harpaz, R., DuMouchel, W., Shah, N. H., Madigan, D., Ryan, P., & Friedman, C. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.50 · Cited by 393
Self-citationHarpaz, R., DuMouchel, W., LePendu, P., Bauer-Mehren, A., Ryan, P., & Shah, N. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.24 · Cited by 333
Pharmacovigilance: methods, recent developments and future perspectives
Härmark, L., & van Grootheest, A. C. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0475-9 · Cited by 289
Metadata
- Authors
- Hauben, M., Madigan, D., Gerrits, C. M., Walsh, L., & Van Puijenbroek, E. P.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa Healthcare
- Published
- 2005-09
- Volume
- 4
- Issue
- 5
- Pages
- 929-948
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2147598330
- Cited by
- 276
- References
- 49
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.